Internal Reference Number: FOI_7106
Date Request Received: 31/03/2023 00:00:00
Date Request Replied To: 11/04/2023 00:00:00
This response was sent via: By Email
Request Summary: Dabrafenib + Trametinib in cancer treatment
Request Category: Private Individuals
Question Number 1: I would be grateful if you could please answer these questions relating to the usage of Dabrafenib + Trametinib in cancer treatment. A) Over the previous 6 months, how many patients for the following diseases have been treated with a combination of Dabrafenib + Trametinib: i) Metastatic Melanoma ii) Adjuvant Melanoma iii) BRAF mutated Lung Cancer | |
Answer To Question 1: i) We don’t treat melanoma with SACt at this Trust ii) We don’t treat melanoma with SACt at this Trust iii) <5 | |
To return to the list of all the FOI requests please click here |
Our staff at SA¹ú¼Ê´«Ã½ Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.